Hoya Group02.03.16
PENTAX Medical, a division of Hoya Group, has announced the appointment of Gerald W. Bottero to the position of global president as of Feb. 1.
"HOYA Group is pleased to have Gerald W. Bottero lead the global division of PENTAX Medical," said Hiroshi Suzuki, president/CEO of Hoya Group. "Mr. Bottero brings a wealth of knowledge, insight and experience from his various global executive roles within Hoya, especially from our Life Care divisions. He has a proven track record of delivering results through developing and implementing strategic and operational changes in a global multicultural environment. We expect his leadership to further advance the PENTAX Medical growth strategy.”
Bottero joined Hoya Corporation in 1988 and has served Hoya in a number of information technology and life care segments. Most recently, he was the president of Hoya Vision Care from April 2005 through September 2014. Before that he served as president of Hoya Conbio, a medical laser firm focused on dermatology and hard tissue dentistry, and has also served as Hoya’s representative on the Boards of Directors of Decibel Instruments (intra-canal hearing aids) and Lifespex Inc. (early detection of cervical cancer).
“I am truly honored to support the global professionals of PENTAX Medical,” said Bottero. “Our mission is to 'lead the leading edge' in intelligent, software-rich endoscopic solutions for the early detection and treatment of cancer. Patients comprise the center of our universe; every day in every way, our job is to help doctors, nurses and biomeds improve the quality of patients’ lives. We are very excited about our opportunities, and by the feedback we have received from customers regarding new technologies we are developing for interactive imaging, single-use devices, mobility and scalable platforms.”
Headquartered in Japan, PENTAX Medical provides endoscopic endoscopic imaging devices and solutions to the global medical community.
"HOYA Group is pleased to have Gerald W. Bottero lead the global division of PENTAX Medical," said Hiroshi Suzuki, president/CEO of Hoya Group. "Mr. Bottero brings a wealth of knowledge, insight and experience from his various global executive roles within Hoya, especially from our Life Care divisions. He has a proven track record of delivering results through developing and implementing strategic and operational changes in a global multicultural environment. We expect his leadership to further advance the PENTAX Medical growth strategy.”
Bottero joined Hoya Corporation in 1988 and has served Hoya in a number of information technology and life care segments. Most recently, he was the president of Hoya Vision Care from April 2005 through September 2014. Before that he served as president of Hoya Conbio, a medical laser firm focused on dermatology and hard tissue dentistry, and has also served as Hoya’s representative on the Boards of Directors of Decibel Instruments (intra-canal hearing aids) and Lifespex Inc. (early detection of cervical cancer).
“I am truly honored to support the global professionals of PENTAX Medical,” said Bottero. “Our mission is to 'lead the leading edge' in intelligent, software-rich endoscopic solutions for the early detection and treatment of cancer. Patients comprise the center of our universe; every day in every way, our job is to help doctors, nurses and biomeds improve the quality of patients’ lives. We are very excited about our opportunities, and by the feedback we have received from customers regarding new technologies we are developing for interactive imaging, single-use devices, mobility and scalable platforms.”
Headquartered in Japan, PENTAX Medical provides endoscopic endoscopic imaging devices and solutions to the global medical community.